Aquestive Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $10,003 | $8,720 | $11,867 | $13,542 |
Gross Profit | 5,442 | 5,068 | 7,347 | 9,105 |
EBITDA | -9,132 | -15,763 | -12,698 | -7,152 |
EBIT | -9,272 | -18,652 | -12,845 | -7,311 |
Net Income | -13,548 | -22,930 | -17,055 | -11,509 |
Net Change In Cash | 10,003 | 8,720 | 11,867 | 13,542 |
Free Cash Flow | -8,021 | -23,535 | -6,504 | -11,960 |
Cash | 60,536 | 68,657 | 71,546 | 77,893 |
Basic Shares | 99,326 | 95,497 | 91,199 | 91,082 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $57,561 | $50,583 | $47,680 | $50,832 |
Gross Profit | 39,689 | 29,752 | 28,294 | 35,843 |
EBITDA | -26,616 | 1,182 | -39,580 | -45,114 |
EBIT | -27,334 | -163 | -41,967 | -48,078 |
Net Income | -44,137 | -7,870 | -54,410 | -70,539 |
Net Change In Cash | 57,561 | 50,583 | 47,680 | 50,832 |
Cost of Revenue | -3,783 | |||
Free Cash Flow | -35,918 | -7,375 | -12,313 | -33,892 |
Cash | 71,546 | 23,872 | 27,273 | 28,024 |
Basic Shares | 86,726 | 61,255 | 48,734 | 38,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.14 |
2025-03-31 | -$0.22 |
2024-12-31 | -$0.16 |
